Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delirium after transfemoral TAVR under monitored anesthesia care: remimazolam vs dexmedetomidine
KCT0007245Phase 4Terminated
- Sponsor
- Hana Pharm
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and dexmedetomidine in aortic stenosis (AS) (2 arms), sponsored by Hana Pharm. Started Jan 2023; status: terminated.
02
Drugs
remimazolamdexmedetomidine
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on KCT0007245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007245.